These medicines will come in the form of pills, inhalers, solutions and creams. Currently Canadians are only able to get medical marijuana in smokable or oil form.

Canopy Growth Corp hopes that offering its treatment in more traditional medical drug forms will allow its medicines to compete with more established treatments. They hope that these new medicines will help to convince doctors and insurers that marijuana can be a mainstream medicine.

Approximately 70 companies have permission from Health Canada, the nation’s health department, to grow and sell cannabis for medical uses. However, Canopy Growth Corp is one of few companies attempting to kick off the second wave of medical cannabis.

These new medicines will be sold under the Canopy Health Innovation brand.

Canopy Growth Corp began their expansion into the pharmaceuticals market in 2016. Canada’s relaxed laws on marijuana allowed the company to get a head start on capturing the market.